Publication | Closed Access

Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit

Alzheimer's DiseaseMedicineDementiaCerebrospinal FluidVascular DementiaNeuropharmacologyNeurochemical BiomarkersCognitive BenefitNeurologyNeuroscienceCerebral Blood FlowNeuropathologyPharmacologyNeurochemistryLewy Body Dementia